A detailed history of Beaumont Financial Partners, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 2,209 shares of CRL stock, worth $439,723. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,209
Previous 2,116 4.4%
Holding current value
$439,723
Previous $453,000 3.97%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $16,966 - $23,300
93 Added 4.4%
2,209 $435,000
Q2 2022

Aug 04, 2022

BUY
$204.13 - $302.4 $612 - $907
3 Added 0.14%
2,116 $453,000
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $5,589 - $6,874
-15 Reduced 0.7%
2,113 $872,000
Q2 2021

Aug 04, 2021

BUY
$294.17 - $371.65 $625,993 - $790,871
2,128 New
2,128 $787,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Beaumont Financial Partners, LLC Portfolio

Follow Beaumont Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.